chemin demons serv import role variety disease particularly tumor progress number studi report cell major role howe function cc motif chemin ligand ccl prostate cancer remain unknown present studi aim investing mouse model genre treat cbl bcgselplgtmfurj mouse dimethyl aminobiphenyl dab hematoxylin join stain detect histopatholog alter tissue immunohistochemistri hc determine cell provider flow cytometri use detect dab cxcldmab immunofluoresc reveal post express interleukin il transform growth factor gfÎ² survive rate analyze assoc clinic stage also value result pathology significantly greater compare number periphery blood spleen reduce downregul rate decrease admit revert transcriptionquantit polymerase chain reaction analysis mra sample post assoc pathology concur may promote via inhibit cytokine 